Header Logo

Connection

LAURA MARSH to Middle Aged

Back to Details
This is a "connection" page, showing publications LAURA MARSH has written about Middle Aged.
LAURA MARSH
Connection Strength
0.457
Middle Aged
  1. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):520-8.
    View in: PubMed
    Score: 0.027
  2. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. J Parkinsons Dis. 2013; 3(4):603-8.
    View in: PubMed
    Score: 0.027
  3. Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. J Geriatr Psychiatry Neurol. 2012 Dec; 25(4):233-9.
    View in: PubMed
    Score: 0.026
  4. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry. 2012 Feb; 20(2):123-32.
    View in: PubMed
    Score: 0.025
  5. Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011; 23(4):417-24.
    View in: PubMed
    Score: 0.023
  6. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1333-8.
    View in: PubMed
    Score: 0.021
  7. Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment. Mov Disord. 2009 Feb 15; 24(3):433-7.
    View in: PubMed
    Score: 0.020
  8. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
    View in: PubMed
    Score: 0.020
  9. Pilot screening for prodromal Parkinson's disease in post-9/11 Veterans with probable rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2025 Mar; 132:107309.
    View in: PubMed
    Score: 0.015
  10. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry. 2004 Jan; 19(1):1-8.
    View in: PubMed
    Score: 0.014
  11. Hippocampal volume deficits in alcoholic Korsakoff's syndrome. Neurology. 2003 Dec 23; 61(12):1716-9.
    View in: PubMed
    Score: 0.014
  12. Neuropsychiatric aspects of Parkinson's disease: recent advances. Curr Psychiatry Rep. 2003 May; 5(1):68-76.
    View in: PubMed
    Score: 0.014
  13. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574.
    View in: PubMed
    Score: 0.011
  14. Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. Ann Neurol. 2020 07; 88(1):33-41.
    View in: PubMed
    Score: 0.011
  15. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol. 2020 06; 122:115-128.e1.
    View in: PubMed
    Score: 0.011
  16. Cervical dystonia and substance abuse. J Neurol. 2018 Apr; 265(4):970-975.
    View in: PubMed
    Score: 0.010
  17. Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality. Am J Geriatr Psychiatry. 2018 06; 26(6):700-710.
    View in: PubMed
    Score: 0.009
  18. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 07; 88(7):595-602.
    View in: PubMed
    Score: 0.009
  19. Active Mental Illnesses Adversely Affect Surgical Outcomes. Am Surg. 2016 Dec 01; 82(12):1238-1243.
    View in: PubMed
    Score: 0.009
  20. Factors Associated With Veterans' Access to Permanent Supportive Housing. Psychiatr Serv. 2016 08 01; 67(8):870-7.
    View in: PubMed
    Score: 0.008
  21. Modeling anxiety in Parkinson's disease. Mov Disord. 2016 Mar; 31(3):310-6.
    View in: PubMed
    Score: 0.008
  22. The longitudinal impact of depression on disability in Parkinson disease. Int J Geriatr Psychiatry. 2016 May; 31(5):458-65.
    View in: PubMed
    Score: 0.008
  23. Influence of schizophrenia diagnosis on providers' practice decisions. J Clin Psychiatry. 2015 Aug; 76(8):1068-74; quiz 1074.
    View in: PubMed
    Score: 0.008
  24. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.008
  25. Mental health diagnoses and health care utilization in persons with dementia, Parkinson's disease, and stroke. J Neuropsychiatry Clin Neurosci. 2015; 27(2):e117-21.
    View in: PubMed
    Score: 0.008
  26. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4.
    View in: PubMed
    Score: 0.007
  27. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol. 2014 Jan; 71(1):62-7.
    View in: PubMed
    Score: 0.007
  28. Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1410-7.
    View in: PubMed
    Score: 0.007
  29. Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology. 2013 Sep 17; 81(12):1036-43.
    View in: PubMed
    Score: 0.007
  30. Rasch analysis of anxiety scales in Parkinson's disease. J Psychosom Res. 2013 May; 74(5):414-9.
    View in: PubMed
    Score: 0.007
  31. Ocular motor and sensory function in Parkinson's disease. Ophthalmology. 2012 Jan; 119(1):178-82.
    View in: PubMed
    Score: 0.006
  32. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011 Feb 15; 26(3):407-15.
    View in: PubMed
    Score: 0.006
  33. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord. 2011 Feb 15; 26(3):484-92.
    View in: PubMed
    Score: 0.006
  34. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc. 2011 Jan; 17(1):91-100.
    View in: PubMed
    Score: 0.006
  35. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010 Sep; 67(9):1116-22.
    View in: PubMed
    Score: 0.006
  36. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010 Jun; 67(6):731-8.
    View in: PubMed
    Score: 0.006
  37. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1517-22.
    View in: PubMed
    Score: 0.005
  38. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11.
    View in: PubMed
    Score: 0.005
  39. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008 Apr; 115(4):461-70.
    View in: PubMed
    Score: 0.005
  40. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging. 2005 Aug-Sep; 26(8):1183-92.
    View in: PubMed
    Score: 0.004
  41. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry. 2002 Aug; 159(8):1306-14.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.